ticlopidine has been researched along with Libman-Sacks Disease in 10 studies
Ticlopidine: An effective inhibitor of platelet aggregation commonly used in the placement of STENTS in CORONARY ARTERIES.
ticlopidine : A thienopyridine that is 4,5,6,7-tetrahydrothieno[3,2-c]pyridine in which the hydrogen attached to the nitrogen is replaced by an o-chlorobenzyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We examined the antithrombotic effect of ticlopidine on occlusive thrombi of small coronary arteries in (NZWxBXSB)F1 [(WxB)F1] male mice with myocardial infarction (MI) and systemic lupus erythematosus (SLE)." | 7.69 | Antithrombotic effect of ticlopidine on occlusive thrombi of small coronary arteries in (NZWxBXSB)F1 male mice with myocardial infarction and systemic lupus erythematosus. ( Fujiwara, H; Nakamura, Y; Shibata, Y; Suzuka, H; Tanaka, M; Yoshifusa, H, 1995) |
| "We examined the antithrombotic effect of ticlopidine on occlusive thrombi of small coronary arteries in (NZWxBXSB)F1 [(WxB)F1] male mice with myocardial infarction (MI) and systemic lupus erythematosus (SLE)." | 3.69 | Antithrombotic effect of ticlopidine on occlusive thrombi of small coronary arteries in (NZWxBXSB)F1 male mice with myocardial infarction and systemic lupus erythematosus. ( Fujiwara, H; Nakamura, Y; Shibata, Y; Suzuka, H; Tanaka, M; Yoshifusa, H, 1995) |
| "Hemolytic uremic syndrome (HUS), thrombotic thrombocytopenic purpura (TTP), and several other conditions are associated with TMA." | 2.44 | The thrombotic microangiopathies. ( Copelovitch, L; Kaplan, BS, 2008) |
| "Systemic lupus erythematosus is a chronic inflammatory disorder that predisposes to acute coronary thrombosis." | 1.37 | Effective management of acute coronary thrombosis in a young woman with lupus using aggressive medical therapy. ( Matthai, WH; Patel, PJ; Untereker, WJ, 2011) |
| "Ticlopidine hydrochloride is a platelet aggregation inhibitor that has been associated with thrombotic thrombocytopenic purpura, which is believed to be immune mediated." | 1.31 | Ticlopidine-induced lupus: a report of 4 cases. ( Berman, RS; Spiera, H; Spiera, RF; Werner, AJ, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 6 (60.00) | 29.6817 |
| 2010's | 3 (30.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yokoyama, T | 1 |
| Usui, T | 1 |
| Kiyama, K | 1 |
| Nakashima, R | 1 |
| Yukawa, N | 1 |
| Kawabata, D | 1 |
| Nojima, T | 1 |
| Ohmura, K | 1 |
| Fujii, T | 1 |
| Mimori, T | 1 |
| Duffau, P | 1 |
| Seneschal, J | 1 |
| Nicco, C | 1 |
| Richez, C | 1 |
| Lazaro, E | 1 |
| Douchet, I | 1 |
| Bordes, C | 1 |
| Viallard, JF | 1 |
| Goulvestre, C | 1 |
| Pellegrin, JL | 1 |
| Weil, B | 1 |
| Moreau, JF | 1 |
| Batteux, F | 1 |
| Blanco, P | 1 |
| Patel, PJ | 1 |
| Matthai, WH | 1 |
| Untereker, WJ | 1 |
| Spiera, RF | 1 |
| Berman, RS | 1 |
| Werner, AJ | 1 |
| Spiera, H | 1 |
| Yang, CW | 1 |
| Chen, YC | 1 |
| Dunn, P | 1 |
| Chang, MY | 1 |
| Fang, JT | 1 |
| Huang, CC | 1 |
| Wang, L | 1 |
| Erling, P | 1 |
| Bengtsson, AA | 1 |
| Truedsson, L | 1 |
| Sturfelt, G | 1 |
| Erlinge, D | 1 |
| Ohtake, T | 1 |
| Kobayashi, S | 1 |
| Okamoto, K | 1 |
| Oka, M | 1 |
| Maesato, K | 1 |
| Yasu, T | 1 |
| Moriya, H | 1 |
| Olivier, AC | 1 |
| Hollman, JL | 1 |
| Copelovitch, L | 1 |
| Kaplan, BS | 1 |
| Suzuka, H | 1 |
| Fujiwara, H | 1 |
| Tanaka, M | 1 |
| Yoshifusa, H | 1 |
| Nakamura, Y | 1 |
| Shibata, Y | 1 |
2 reviews available for ticlopidine and Libman-Sacks Disease
| Article | Year |
|---|---|
Two cases of late-onset drug-induced lupus erythematosus caused by ticlopidine in elderly men.
Topics: Aged; Aged, 80 and over; Aging; Autoantibodies; Histones; Humans; Lupus Erythematosus, Systemic; Mal | 2010 |
The thrombotic microangiopathies.
Topics: Hematopoietic Stem Cell Transplantation; Hemolytic-Uremic Syndrome; HIV Infections; Humans; Lupus Er | 2008 |
1 trial available for ticlopidine and Libman-Sacks Disease
| Article | Year |
|---|---|
Thrombotic thrombocytopenic purpura (TTP): initial treatment with plasma exchange plus steroids and immunosuppressive agents for relapsing cases.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anemia, Hemolytic; Bilirubin; Biomarkers; Combined Modal | 2003 |
7 other studies available for ticlopidine and Libman-Sacks Disease
| Article | Year |
|---|---|
Platelet CD154 potentiates interferon-alpha secretion by plasmacytoid dendritic cells in systemic lupus erythematosus.
Topics: Animals; Autoantibodies; Blood Platelets; CD40 Ligand; Clopidogrel; Dendritic Cells; Disease Models, | 2010 |
Effective management of acute coronary thrombosis in a young woman with lupus using aggressive medical therapy.
Topics: Adult; Aspirin; Clopidogrel; Coronary Thrombosis; Eptifibatide; Female; Fibrinolytic Agents; Heparin | 2011 |
Ticlopidine-induced lupus: a report of 4 cases.
Topics: Aged; Female; Humans; Lupus Erythematosus, Systemic; Male; Middle Aged; Platelet Aggregation Inhibit | 2002 |
Transcriptional down-regulation of the platelet ADP receptor P2Y(12) and clusterin in patients with systemic lupus erythematosus.
Topics: Adolescent; Adult; Blood Platelets; Blotting, Western; Clopidogrel; Clusterin; Dimerization; Down-Re | 2004 |
Ticlopidine-induced lupus with renal involvement.
Topics: Aged; Fibrinolytic Agents; Glomerulonephritis; Humans; Kidney; Kidney Diseases; Lupus Erythematosus, | 2006 |
Late in-stent thrombosis in a patient with systemic lupus erythematosus and hyperhomocysteinemia while on clopidogrel and aspirin.
Topics: Angioplasty, Balloon, Coronary; Aspirin; Blood Coagulation Disorders; Clopidogrel; Coronary Artery D | 2006 |
Antithrombotic effect of ticlopidine on occlusive thrombi of small coronary arteries in (NZWxBXSB)F1 male mice with myocardial infarction and systemic lupus erythematosus.
Topics: Analysis of Variance; Animals; Antigen-Antibody Complex; Blood Urea Nitrogen; Coronary Disease; Coro | 1995 |